1. Triple-Negative Breast Cancer: the Current Aspects of Pathogenesis and Therapies
   Shinjit Mani et al, 2022, BioNanoScience CrossRef
2. Network pharmacology, molecular docking and molecular dynamics simulation of chalcone scaffold-based compounds targeting breast cancer receptors
   Noor Zafirah Ismail et al, 2023, Journal of Biomolecular Structure and Dynamics CrossRef
3. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
   Reyhaneh Farghadani et al, 2021, Cancers CrossRef
4. Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
   Kyu Sic You et al, 2021, Cancers CrossRef
5. Human Papillomavirus in Breast Carcinogenesis: A Passenger, a Cofactor, or a Causal Agent?
   Rancés Blanco et al, 2021, Biology CrossRef
6. Predicting Multiple Types of Associations Between miRNAs and Diseases Based on Graph Regularized Weighted Tensor Decomposition
   Dong Ouyang et al, 2022, Frontiers in Bioengineering and Biotechnology CrossRef
7. Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer
   Irene A. George et al, 2022, Frontiers in Cell and Developmental Biology CrossRef
8. Marine-Derived Stichloroside C2 Inhibits Epithelial–Mesenchymal Transition and Induces Apoptosis through the Mitogen-Activated Protein Kinase Signalling Pathway in Triple-Negative Breast Cancer Cells
   Chuang Cui et al, 2022, Journal of Oncology CrossRef
9. CTI-2 Inhibits Metastasis and Epithelial-Mesenchymal Transition of Breast Cancer Cells by Modulating MAPK Signaling Pathway
   Junfeng Ke et al, 2021, International Journal of Molecular Sciences CrossRef
10. XMR: an explainable multimodal neural network for drug response prediction
    Zihao Wang et al, 2023, Frontiers in Bioinformatics CrossRef
11. Receptor Tyrosine Kinases and Their Signaling Pathways as Therapeutic Targets of Curcumin in Cancer
    Sareshma Sudhesh Dev et al, 2021, Frontiers in Pharmacology CrossRef
12. Targeting the EGFR signaling pathway in cancer therapy: What’s new in 2023?
    Sushanta Halder et al, 2023, Expert Opinion on Therapeutic Targets CrossRef
13. Identifying liver metastasis-related hub genes in breast cancer and characterizing SPARCL1 as a potential prognostic biomarker
    Mingkuan Chen et al, 2023, PeerJ CrossRef
14. Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies
    Gagan K. Gupta et al, 2020, Cancers CrossRef
15. Nanotechnological Approaches for the Treatment of Triple-Negative Breast Cancer: A Comprehensive Review
    Lahanya Guha et al, 2022, Current Drug Metabolism CrossRef